Nanobiotix S.A. American Depositary Shares (NBTX)

Price$35.46

Value ScoreF

Growth ScoreB

Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)70.42%

Price vs S&P 500 (4W)-26.70%

VGM Score51.73

Market Capitalization$1.83B

All Metrics

Book Value / Share (Quarterly)$0.06

P/TBV (Annual)9.50x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.81

Price vs S&P 500 (YTD)51.41%

Net Profit Margin (TTM)-80.84%

EPS (TTM)$-0.58

10-Day Avg Trading Volume0.21M

EPS Excl Extra (TTM)$-0.58

Revenue Growth (5Y)258.58%

EPS (Annual)$-0.58

ROI (Annual)-67.39%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-122461.58%

Cash / Share (Quarterly)$1.26

Revenue Growth QoQ (YoY)304.48%

ROA (Last FY)-35.36%

Revenue Growth TTM (YoY)-80.24%

EBITD / Share (TTM)$-0.24

ROE (5Y Avg)-124.29%

Operating Margin (TTM)-38.11%

Cash Flow / Share (Annual)$-0.81

P/B Ratio882.19x

P/B Ratio (Quarterly)65.40x

Net Income / Employee (Annual)$-285,654

EV / Revenue (TTM)54.77x

Net Interest Coverage (TTM)-0.89x

ROA (TTM)-42.44%

EPS Incl Extra (Annual)$-0.58

Current Ratio (Annual)1.09x

Quick Ratio (Quarterly)1.05x

3-Month Avg Trading Volume0.25M

52-Week Price Return591.84%

Revenue / Employee (TTM)$353,424

Tangible BV / Share (Quarterly)$0.06

P/S Ratio (Annual)53.33x

Asset Turnover (Annual)0.44x

52-Week High$47.66

Operating Margin (5Y Avg)-133512.98%

EPS Excl Extra (Annual)$-0.58

CapEx CAGR (5Y)38.54%

Tangible BV CAGR (5Y)11.42%

26-Week Price Return78.34%

Quick Ratio (Annual)1.05x

13-Week Price Return7.13%

Total Debt / Equity (Annual)1.60x

Current Ratio (Quarterly)1.09x

Enterprise Value$1.88B

Revenue / Share Growth (5Y)211.90%

Asset Turnover (TTM)0.53x

Book Value / Share Growth (5Y)-6.95%

Revenue / Employee (Annual)$353,424

Pretax Margin (Annual)-80.83%

Cash / Share (Annual)$1.26

3-Month Return Std Dev95.60%

Net Income / Employee (TTM)$-285,654

ROE (Last FY)-175.45%

Net Interest Coverage (Annual)-0.89x

EPS Basic Excl Extra (Annual)$-0.58

Receivables Turnover (TTM)11.60x

Total Debt / Equity (Quarterly)23.58x

EPS Incl Extra (TTM)$-0.58

Receivables Turnover (Annual)11.60x

ROI (TTM)-75.47%

P/S Ratio (TTM)53.33x

Pretax Margin (5Y Avg)-122447.02%

Revenue / Share (Annual)$0.72

Tangible BV / Share (Annual)$0.89

Price vs S&P 500 (52W)567.48%

Year-to-Date Return58.77%

5-Day Price Return-6.07%

EPS Normalized (Annual)$-0.58

ROA (5Y Avg)-64.07%

Net Profit Margin (Annual)-80.84%

Month-to-Date Return-9.05%

Cash Flow / Share (TTM)$-1.90

EBITD / Share (Annual)$-0.24

Operating Margin (Annual)-38.11%

LT Debt / Equity (Annual)1.13x

ROI (5Y Avg)-68.91%

LT Debt / Equity (Quarterly)16.13x

EPS Basic Excl Extra (TTM)$-0.58

P/TBV (Quarterly)65.43x

P/B Ratio (Annual)9.50x

Pretax Margin (TTM)-80.83%

Book Value / Share (Annual)$0.89

Price vs S&P 500 (13W)-1.13%

Beta0.09x

Revenue / Share (TTM)$0.71

ROE (TTM)-300.48%

52-Week Low$3.75

vGradeF

gGradeB

mGradeB

vgmGradeC

Show chart for

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.25

4.17

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
NBTXNanobiotix S.A. American Depositary Shares	F	B	B	$35.46
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

Nanobiotix SA is a clinical-stage biotechnology company developing proprietary nanotechnology to enhance the effectiveness of cancer radiotherapy. Its NanoXray platform amplifies radiation effects within tumor cells without increasing exposure to surrounding healthy tissue. The company's lead candidate, NBTXR3, is being evaluated for cancer immunotherapy applications.